Granules India Limited Stock: price and insider trades · India
Granules India Limited: what insiders have been doing
Every trade that managers of Granules India Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 23 October 2026, brought 5 filings signed by 5 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale. The totals exclude 1 filing filed without an amount.
Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (1,892 companies, median 4 filings), a count of 5 filings is above the norm. The full history, which starts in 2021, counts no purchases against 12 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Granules India Limited Strong Buy (bullish), based on 8 analysts. Average price target: ₹907.25.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 34,188 shares@ ₹438.80EquityPreferential OfferSEBI:e1ba382c4cbf22f97d80707a74928c605b2ca763
- 24,880,342 shares@ ₹146.30WarrantPreferential OfferSEBI:5fdee6a2686eb2c537ddbe2bfbf2b0aa63082cd6
- 34,188 shares@ ₹146.30WarrantPreferential OfferSEBI:2aedd4a265fc5046c4e96ad73cfc24fcb01fca10
- 34,188 shares@ ₹438.80EquityPreferential OfferSEBI:9483ae1cc7e41ab0166c55c0ceb16e99f3c42088
- 4,956,124 shares-MarketSEBI:2baf50c8bd9f1a961620dbbb8354e6a0a7663028
- 40,000 shares@ ₹327.00100.0% of flowEquity SharesSEBI:9cadfe3d551afc095133e94280be4b8e5928ee99
- 4,000 shares@ ₹327.0053.1% of flowEquity SharesSEBI:55187841a7f64b11d4854051d17a66e0b6646992
- 20,000 shares@ ₹327.00100.0% of flowEquity SharesSEBI:3b5aba6075187f90861e86c86d170f0b2a6aae51
- 10,000 shares@ ₹327.00100.0% of flowEquity SharesSEBI:0f16d0af3c9f8ded65dbd3e5359c8467b27db4fb
- 40,000 shares@ ₹327.00100.0% of flowEquity SharesSEBI:1d8f9d9ce4487b4263e53a78df6b0e2e0059b1ae
- 60,000 shares@ ₹327.00100.0% of flowEquity SharesSEBI:d190c1475b8d025d2a67320831332ab545273655
- 17,660 shares@ ₹327.00100.0% of flowEquity SharesSEBI:8d9da40b0c37dbb996f30d149487996e5377ebe9
- 30,000 shares@ ₹327.00100.0% of flowEquity SharesSEBI:de7d86758a406b281099f2fcb3767ca71c4d1046
- 3,000 shares@ ₹395.000.0007% mcap100.0% of flowEquity SharesSEBI:e6a32a329bf599b16e4e96871fac8b001fff7c6e
- 20,000 shares@ ₹388.05750.0048% mcap100.0% of flowEquity SharesSEBI:fc8cb06fc3cc3f8bc7ebcb7878c3f24dc5022a81
- 33,000 shares@ ₹332.87880.0067% mcap97.3% of flowEquity SharesSEBI:379cf579422df48d47b6c94fc0b79a3c3e563984
- 4,000 shares@ ₹374.7750.0007% mcap46.9% of flowEquity SharesSEBI:346b61309c05b209f8f3d12b3f50c18bf5b8ff6c
- 932 shares@ ₹332.500.0002% mcap2.7% of flowEquity SharesSEBI:13060f42a07459fddd07c379235e2c3e7121c071
- 47,177 shares@ ₹329.7660.0095% mcap12.5% of flowEquity SharesSEBI:1b57bbdab1f59381b615193e56a1c75684d5659e
- 21,400 shares@ ₹333.85330.0043% mcap5.7% of flowEquity SharesSEBI:d7535f4945817446a61037487688e15ce51675df
- 23,000 shares@ ₹326.92770.0046% mcap6.1% of flowEquity SharesSEBI:6a9d09cf1d03eb76fd75ce6244097d5095e74fcd
- 59,800 shares@ ₹318.19250.012% mcap15.3% of flowEquity SharesSEBI:5c9b4d158d83e8a631689d83280e5084c97be3f0
- 109,000 shares@ ₹321.21960.021% mcap28.1% of flowEquity SharesSEBI:590bd5e7a5414e0c841e5f7461326f8da82699bb
- 124,000 shares@ ₹324.34560.024% mcap32.2% of flowEquity SharesSEBI:74a1a0f479cd1126ea28b5f65de57f3e89e784af
24 of 24 declarations
About Granules India Limited
Granules India Limited is a pharmaceutical company based in India, specializing in the manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
